Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

9.57
Delayed Data
As of May 23
 -0.43 / -4.30%
Today’s Change
7.67
Today|||52-Week Range
18.00
-3.14%
Year-to-Date

Today’s Trading

Previous close10.00
Today’s open9.98
Day’s range9.54 - 10.11
Volume544,525
Average volume (3 months)612,225
Market cap$1.0B
Data as of 4:00pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)+9.56%
Earnings growth (this year)-12.14%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)+8.40%
P/E ratioNM
Price/Sales11.51
Price/Book20.04

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.59+1.17%
PCRXPacira Pharmaceutica...+0.90+2.64%
INVAInnoviva Inc+0.01+0.07%
MYOKMyoKardia Inc-2.10-4.17%
Data as of 4:02pm ET, 05/23/2018

Financials

Next reporting dateJuly 31, 2018
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$90.3M
Annual profit (last year)-$129.1M
Net profit margin-142.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts